These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21507057)

  • 1. Evaluation of the atrophogenic potential of topical corticosteroids in pediatric dermatology patients.
    Hong E; Smith S; Fischer G
    Pediatr Dermatol; 2011; 28(4):393-6. PubMed ID: 21507057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
    Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
    Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
    Murrell DF; Calvieri S; Ortonne JP; Ho VC; Weise-Riccardi S; Barbier N; Paul CF
    Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement.
    Mooney E; Rademaker M; Dailey R; Daniel BS; Drummond C; Fischer G; Foster R; Grills C; Halbert A; Hill S; King E; Leins E; Morgan V; Phillips RJ; Relic J; Rodrigues M; Scardamaglia L; Smith S; Su J; Wargon O; Orchard D
    Australas J Dermatol; 2015 Nov; 56(4):241-51. PubMed ID: 25752907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
    Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
    Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis.
    Luger TA; Lahfa M; Fölster-Holst R; Gulliver WP; Allen R; Molloy S; Barbier N; Paul C; Bos JD
    J Dermatolog Treat; 2004 Jun; 15(3):169-78. PubMed ID: 15204150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacists' knowledge about use of topical corticosteroids in atopic dermatitis: Pre and post continuing professional development education.
    Smith SD; Lee A; Blaszczynski A; Fischer G
    Australas J Dermatol; 2016 Aug; 57(3):199-204. PubMed ID: 25846602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
    Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
    Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus ointment: utilization patterns in children under age 2 years.
    Housman TS; Norton AB; Feldman SR; Fleischer AB; Simpson EL; Hanifin JM; Antaya RJ
    Dermatol Online J; 2004 Jul; 10(1):2. PubMed ID: 15347484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cutaneous infections in bullous pemphigoid patients treated with topical corticosteroids].
    Boughrara Z; Ingen-Housz-Oro S; Legrand P; Duong TA; Roujeau JC
    Ann Dermatol Venereol; 2010 May; 137(5):345-51. PubMed ID: 20470914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing the treatment of atopic dermatitis in children: a review of the benefit/risk ratio of methylprednisolone aceponate.
    Blume-Peytavi U; Wahn U
    J Eur Acad Dermatol Venereol; 2011 May; 25(5):508-15. PubMed ID: 21492244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of topical corticosteroids in atopic eczema: an umbrella review.
    Axon E; Chalmers JR; Santer M; Ridd MJ; Lawton S; Langan SM; Grindlay DJC; Muller I; Roberts A; Ahmed A; Williams HC; Thomas KS
    BMJ Open; 2021 Jul; 11(7):e046476. PubMed ID: 34233978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cost-utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema.
    Pitt M; Garside R; Stein K
    Br J Dermatol; 2006 Jun; 154(6):1137-46. PubMed ID: 16704646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral cyclosporin plus topical corticosteroid therapy diminishes bone mass in children with eczema.
    Pedreira CC; King E; Jones G; Moore E; Zacharin M; Varigos G; Cameron FJ
    Pediatr Dermatol; 2007; 24(6):613-20. PubMed ID: 18035982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alclometasone dipropionate 0.05% vs hydrocortisone 1.0%: potential to induce cutaneous atrophy in children.
    Kuokkanen K; Sillantaka I
    Clin Ther; 1987; 9(2):223-31. PubMed ID: 3568065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
    Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unveiling the potential: Enhancing caregiver knowledge through video education to address topical corticosteroid concerns in children with eczematous dermatitis.
    Sitthisan M; Wananukul S; Chatproedprai S; Tempark T; Chantawarangul K
    Pediatr Dermatol; 2024; 41(2):221-228. PubMed ID: 38126606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid-induced periorificial dermatitis in children--clinical features and response to azelaic acid.
    Jansen T; Melnik BC; Schadendorf D
    Pediatr Dermatol; 2010; 27(2):137-42. PubMed ID: 19804495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term management of facial atopic eczema with pimecrolimus cream 1% in paediatric patients with mild to moderate disease.
    Zuberbier T; Bräutigam M
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):718-21. PubMed ID: 18312323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.